ArticleEuropean urology2021

Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical Trial.

Markus Grabbert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.